Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(17%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
17%
Ph phase_3
2
33%
Ph phase_2
3
50%

Phase Distribution

1

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
3(50.0%)
Phase 3Large-scale testing
2(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(3)
Other(1)

Detailed Status

Completed3
Not yet recruiting1
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (16.7%)
Phase 23 (50.0%)
Phase 32 (33.3%)

Trials by Status

not_yet_recruiting117%
unknown117%
completed350%
recruiting117%

Recent Activity

1 active trials
Showing 5 of 6
recruitingphase_3

A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia

NCT07230730
completedphase_2

Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemic

NCT06109831
completedphase_3

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia

NCT06723652
completedphase_2

Evaluate the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia

NCT06009393
not_yet_recruitingphase_2

Evaluate the Long-term Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia

NCT07133815
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07230730Phase 3

A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia

Recruiting
NCT06109831Phase 2

Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemic

Completed
NCT06723652Phase 3

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia

Completed
NCT06009393Phase 2

Evaluate the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia

Completed
NCT07133815Phase 2

Evaluate the Long-term Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia

Not Yet Recruiting
NCT05432544Phase 1

Safety and Tolerability of SHR-1918 in Healthy Subjects

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6